Australia markets closed

China SXT Pharmaceuticals, Inc. (SXTC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0600-0.0200 (-1.85%)
At close: 04:00PM EDT
1.0800 +0.02 (+1.89%)
After hours: 07:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
1,703
1,972
2,602
4,778
Cost of revenue
1,078
1,545
1,351
1,938
Gross profit
624.928
426.271
1,252
2,840
Operating expenses
Selling general and administrative
14,431
6,034
6,441
5,037
Total operating expenses
14,431
6,034
6,441
5,037
Operating income or loss
-13,806
-5,608
-5,190
-2,197
Total other income/expenses net
98.773
149.513
-181.581
871.65
Income before tax
-14,136
-5,935
-5,408
-2,941
Income tax expense
0
0
328.146
-192.683
Income from continuing operations
-14,136
-5,935
-5,736
-2,748
Net income
-14,136
-5,935
-5,736
-2,748
Net income available to common shareholders
-14,136
-5,935
-5,736
-2,748
Basic EPS
-22.23
-22.23
-137.93
-95.47
Diluted EPS
-22.23
-22.23
-137.93
-95.47
Basic average shares
266.973
266.973
41.59
28.781
Diluted average shares
266.973
266.973
41.59
28.781